Since c-Myc-dependent mammary tumours seldom contain mutated p53, in striking contrast to lymphomas, future studies could productively address the interactions between p53 and Bax in distinguishing differential, c-Myc effects on tumorigenesis in these two tissue types. The gene discussed is MYC; the disease is breast cancer.